BrainDTech is focused on the early diagnosis and monitoring of neurological and neurodegenerative disorders.
early diagnosis and monitoring of neurological and neurodegenerative diseases in liquid biopsies, based on miRNA from microglial microvesicles.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 4, 2018 | Series B | €500K | 3 | — | — | Detail |
Mar 1, 2017 | Series A | €220K | 2 | — | — | Detail |
Sep 1, 2016 | Seed | €400K | 1 | — | — | Detail |